Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ontrak, Inc.
  6. News
  7. Summary
    OTRK   US6833731044

ONTRAK, INC.

(OTRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OTRK Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ontrak, Inc. Investors of Class Action and Lead Plaintiff Deadline: May 3, 2021

04/30/2021 | 11:01am EDT

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ontrak, Inc. ("Ontrak" or the "Company") (NASDAQ: OTRK) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Ontrak securities between November 5, 2020 and February 26, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/otrk.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) that Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) that, as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) that, because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/otrk or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Ontrak you have until May 3, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.


ę Business Wire 2021
All news about ONTRAK, INC.
05/20ONTRAKá : Optima Health Selects Ontrak for all Medicare and Medicaid Business
BU
05/11ONTRAKá : to Present at the 2021 RBC Capital Markets Global Healthcare Conferenc..
BU
05/10ONTRAKá : B. Riley Lowers Ontrak's PT to $58 from $73 on Lower Estimates, Keeps ..
MT
05/06ONTRAKá : Earnings Flash (OTRK) ONTRAK Posts Q1 Revenue $28.7M, vs. Street Est o..
MT
05/06ONTRAKá : Earnings Flash (OTRK) ONTRAK Reports Q1 Loss $-0.17, vs. Street Est of..
MT
05/06ONTRAK, INC.á : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/06ONTRAKá : Announces 2021 First Quarter Financial Results
BU
05/06ONTRAKá : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/05ONTRAKá : Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferre..
BU
05/04ONTRAKá : Landmark Behavioral Health Treatment Effect Study Shows 64% Reduction ..
BU
More news
Financials (USD)
Sales 2021 84,2 M - -
Net income 2021 -41,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -16,1x
Yield 2021 -
Capitalization 624 M 624 M -
Capi. / Sales 2021 7,40x
Capi. / Sales 2022 5,07x
Nbr of Employees 724
Free-Float 40,3%
Chart ONTRAK, INC.
Duration : Period :
Ontrak, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONTRAK, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 40,86 $
Last Close Price 35,16 $
Spread / Highest target 65,0%
Spread / Average Target 16,2%
Spread / Lowest Target -8,99%
EPS Revisions
Managers and Directors
NameTitle
Jonathan E. Mayhew Chief Executive Officer
Curt Medeiros President & Chief Operating Officer
Brandon H. LaVerne Chief Financial Officer
Terren S. Peizer Executive Chairman
Julia Wright Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ONTRAK, INC.-43.10%624
CVS HEALTH CORPORATION20.64%108 485
HCA HEALTHCARE, INC.22.44%66 581
REDE D'OR SÃO LUIZ S.A.-1.99%25 756
LABORATORY CORPORATION OF AMERICA HOLDINGS27.83%25 405
FRESENIUS MEDICAL CARE AG & CO. KGAA2.84%24 355